So the FDA changed the labeling on metformin a while back and made it a little easier to use the drug in more patients who have poor kidney function. Whenever changes like this happen, I like to take a little time and digest the changes. From a recent Medscape...
What to do with antiplatelet medications in the setting of anemia has always been a huge challenge for me. Here’s a scenario with some questions to think about. A 64 year old female has a history of CAD, hyperlipidemia, hypertension, CABG, depression, anemia,...
An 81 year old male presents with worsening confusion over a period of about 3-6 months. The primary provider is considering an Rx for Aricept as she feels that this is Alzheimer’s dementia in the mild to moderate stage. What do we do as pharmacists? One of the...
The decision to discontinue anti-platelet medications is a challenging one. Antiplatelet therapy is something I see everyday in practice. Aspirin and clopidogrel are the two most common medications I see utilized. What’s often the greatest challenge with these...
With changing antidepressants, there are lots of considerations to consider. Are we going to augment, switch to a different antidepressant in the same class, or switch to a different class? Are we changing up the medication regimen because of side effects or...
We all know the negatives of warfarin, but lets take a look at the advantages of warfarin. NOACs are gaining in popularity, no doubt about that. No matter which anticoagulant we are using, we must recognize that there are always positives and negatives. It is...
